Polypeptide Systems

PolyPeptide Group is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of proprietary and generic GMP-grade peptides and oligonucleotides. The company supports pharmaceutical and biotech clients throughout the entire product lifecycle, from early-stage research and clinical development to large-scale commercial manufacturing. With a heritage dating back to 1952, PolyPeptide operates a network of manufacturing facilities across Europe, the United States, and India. Their technical expertise encompasses solid-phase and liquid-phase peptide synthesis, as well as complex purification and analytical services. The company is publicly traded on the SIX Swiss Exchange and is a critical partner in the production of blockbuster metabolic and oncology therapeutics.